GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Byhealth Co 300146.SZ · CNY

Consumer Staples · Shenzhen · 🇨🇳 China

Compare

10.33

-0.58%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Byhealth Co

Its shares trade on Shenzhen under the ticker 300146.SZ. It has been listed since 15 December 2010. In the fiscal year to 31 December 2025, it reported revenue of CN¥6.22bn and net income of CN¥782.2m. At that date it held total assets of CN¥14.02bn and shareholders' equity of CN¥11.11bn.

By-health Co., Ltd. engages in the research, development, production, and sales of vitamin and dietary supplements. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2010-12-15. The firm's main products include protein powders, collagen protein, vitamin C tablets, vitamin B tablets, natural vitamin E capsules, vitamin A and D soft capsules, calcium and vitamin D soft capsules, bovine colostrum calcium tablets, bone collagen calcium tablets, spirulina tablets, grape seed tablets, wheat germ oil soft capsules, deep-sea fish oil soft capsules, tuna oil soft capsules, propolis soft capsules, soybean phospholipids soft capsules and squalene soft capsules, among others. The firm distributes products both in the domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Products
Listed since
15 Dec 2010
Employees
3,888

Leadership

Pay as last reported

  • Mr. Yunchao LiangChairman of the Board, since 2008CN¥408,100
  • Mr. Shuisheng LiangVice Chairman of the Board, since 2008CN¥3.5m
  • Mr. Bailin HeChief Financial OfficerCN¥1.1m
  • Mr. Liangping CaiChief Operating Officer, Deputy General ManagerCN¥3.5m
  • Mr. Zhicheng LinGeneral Manager, Director, since 2012CN¥2.3m
  • Mr. Hong ChenDeputy General Manager, since 2008CN¥3.1m
  • Ms. Jinyin TangSecretary of the BoardCN¥801,300
  • Mr. Hui TangDirector, since 2008CN¥2.3m
  • Mr. Chuanyuan DengIndependent DirectorCN¥120,200
  • Mr. Yuming HuIndependent DirectorCN¥120,200
  • Mr. Heng LiuIndependent DirectorCN¥120,200

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
67
Environment
96
Social
69
Governance
36
Direct emissions (scope 1)
1,334.96 t
Energy emissions (scope 2)
18,052.48 t
Value chain emissions (scope 3)
198,994.59 t
Women in the workforce
55.80372%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Byhealth Co Ltd possesses several strengths that contribute to its success in the market. Firstly, the company has a diverse portfolio of high-quality products, including nutritional supplements, personal care items, and healthcare devices. This extensive range enables Byhealth to cater to a wide target audience and capitalize on various market segments.
  • Secondly, Byhealth has established strong brand recognition and reputation, both domestically and internationally. The company prides itself on manufacturing products that meet stringent quality standards and are backed by extensive research and development efforts. This brand reputation helps Byhealth gain customer trust and loyalty.
  • Additionally, Byhealth benefits from a well-developed distribution network and strategic partnerships with retailers. This allows the company to reach a broad customer base efficiently and expand its market presence.

Weaknesses

  • Despite Byhealth's strengths, there are some areas where the company faces challenges. One weakness is its dependency on a few key suppliers for raw materials. Any disruption or issues with these suppliers may impact the company's production and supply chain, leading to potential delays and increased costs.
  • Another weakness lies in Byhealth's limited geographical diversification. The company primarily operates in a few select markets, making it susceptible to regional economic fluctuations and regulatory changes. Expanding into new markets could help mitigate this weakness.

Opportunities

  • Byhealth has several opportunities to explore for future growth. Firstly, the increasing global demand for health and wellness products presents a favorable market environment. Byhealth can focus on innovative product development and capitalize on emerging trends to capture a larger market share.
  • Moreover, Byhealth can consider expanding its online presence and e-commerce capabilities. With the rise of digital platforms, selling directly to consumers online can enhance accessibility and create additional revenue streams.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.